X-37 rakes in $14.5 mln Series A

South San Francisco-based X-37 LLC, an artificial intelligence-enabled drug discovery company, has secured $14.5 million in Series A financing. DCVC Bio led the round with participation from Alpha Intelligence Capital and Hemi Ventures.

North AmericaUSHealthcareBriefs